How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 35, Issue 6, Pages 899-904
Publisher
Oxford University Press (OUP)
Online
2020-05-20
DOI
10.1093/ndt/gfaa130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve
- (2020) Jay A. Fishman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain
- (2020) Mario Fernández‐Ruiz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID-19 in kidney transplant recipients
- (2020) Ilaria Gandolfini et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter
- (2020) Marcus R. Pereira et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal
- (2020) Verónica López et al. NEFROLOGIA
- Covid-19 and Kidney Transplantation
- (2020) Enver Akalin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
- (2020) Ashley Barlow et al. PHARMACOTHERAPY
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- (2020) Wei Cao et al. Open Forum Infectious Diseases
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
- (2020) Federico Alberici et al. KIDNEY INTERNATIONAL
- COVID-19 infection in kidney transplant recipients
- (2020) Debasish Banerjee et al. KIDNEY INTERNATIONAL
- Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
- (2019) Yue Ma-Lauer et al. ANTIVIRAL RESEARCH
- Combination Drug Products for HIV-A Word of Caution for the Transplant Clinician
- (2016) S. J. Patel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Influenza and other respiratory virus infections in solid organ transplant recipients
- (2014) O. Manuel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Drug–Drug Interactions Between Antiretroviral and Immunosuppressive Agents in HIV-Infected Patients After Solid Organ Transplantation: A Review
- (2012) Erik M. van Maarseveen et al. AIDS PATIENT CARE AND STDS
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
- (2012) Javier Carbajo-Lozoya et al. VIRUS RESEARCH
- Management of viral infections in solid organ transplant recipients
- (2011) Raymund R Razonable Expert Review of Anti-Infective Therapy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started